Anastasios Raptis

UPMC Hillman Cancer Center — United States

Medicine · Health Sciences

18h-index2.0kcitations100works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(39), Multiple Myeloma Research and Treatments(33), Hematopoietic Stem Cell Transplantation(20), Protein Degradation and Inhibitors(15), Peptidase Inhibition and Analysis(14)

Publications98 total

Real-world outcomes of cytarabine consolidation in older patients with acute myeloid leukemia.
Journal of Clinical Oncology·2025
Prior Exposure to BCMA-Directed Therapy Is Associated with Inferior Outcomes after BCMA CAR-T in Multiple Myeloma – a Single Institution Experience
Transplantation and Cellular Therapy·2025
A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia
Haematologica·2024· 1 citedOpen Access
Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients
American Journal of Hematology·2024· 2 citedOpen Access
Rapid Emergence of Potentially Transmissible Severe Acute Respiratory Syndrome Coronavirus 2 With Resistance to Combination Monoclonal Antibody Therapy
Open Forum Infectious Diseases·2023· 1 citedOpen Access
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2–Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients
Clinical Infectious Diseases·2023· 15 citedOpen Access
Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy
Leukemia & lymphoma/Leukemia and lymphoma·2023Open Access
Intravascular Lymphoma – The Creepy Crawler: A Case Series and Brief Literature Review
Cancer Diagnosis & Prognosis·2022· 3 citedOpen Access
Trial-in-Progress: A Phase 2 Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Acute Myeloid Leukemia That Persisted after the 1st Induction Regimen
Blood·2022
A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML
Leukemia & lymphoma/Leukemia and lymphoma·2022Open Access
Rates and Predictors of Nonadherence to the Post-Allogeneic Hematopoietic Cell Transplantation Medical Regimen in Patients and Caregivers
Transplantation and Cellular Therapy·2021· 17 citedOpen Access
Patient‐reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study
British Journal of Haematology·2021· 11 citedOpen Access
A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy
Supportive Care in Cancer·2021· 16 cited
Poster: MM-186: HORIZON (OP-106): Melflufen Plus Dexamethasone in 55 Patients with Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD): Subgroup Analysis
Clinical Lymphoma Myeloma & Leukemia·2021
Poster: MM-171: Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Exposed or Refractory to Prior Alkylators: A Pooled Analysis of the O-12-M1 and HORIZON Studies
Clinical Lymphoma Myeloma & Leukemia·2021
MM-186: HORIZON (OP-106): Melflufen Plus Dexamethasone in 55 Patients with Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD): Subgroup Analysis
Clinical Lymphoma Myeloma & Leukemia·2021· 1 cited
MM-171: Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Exposed or Refractory to Prior Alkylators: A Pooled Analysis of the O-12-M1 and HORIZON Studies
Clinical Lymphoma Myeloma & Leukemia·2021
Intravascular lymphoma - The creepy crawler: A case series and brief literature review
2021· 1 citedOpen Access
Melflufen plus dexamethasone (dex) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) exposed/refractory to prior alkylators: A pooled analysis of the O-12-M1 and HORIZON studies.
Journal of Clinical Oncology·2021· 1 cited
The Clinical Outcome in Patients with Peritoneal Metastasis
2020Open Access
page 1 of 5Next →

Frequent Co-authors

Mounzer Agha(20), Michael Boyiadzis(16), Jing‐Zhou Hou(15), Rafic Farah(14), Annie Im(13), Robert L. Redner(12), Kathleen Dorritie(11), Albert Oriol(10), Michèle Cavo(10), Alison R. Sehgal(10), Alessandra Larocca(9), María‐Victoria Mateos(9), Seah H. Lim(8), Paul G. Richardson(8), Paula Rodríguez‐Otero(8), Xavier Leleu(8), Cyrille Touzeau(8), Agne Paner(8), Christopher Maisel(8), Amitabha Mazumder(8)